These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 24652347

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Impact of medication discontinuation on increased intestinal FDG accumulation in diabetic patients treated with metformin.
    Oh JR, Song HC, Chong A, Ha JM, Jeong SY, Min JJ, Bom HS.
    AJR Am J Roentgenol; 2010 Dec; 195(6):1404-10. PubMed ID: 21098202
    [Abstract] [Full Text] [Related]

  • 3. Metformin-related colonic glucose uptake; potential role for increasing glucose disposal?--A retrospective analysis of (18)F-FDG uptake in the colon on PET-CT.
    Bahler L, Stroek K, Hoekstra JB, Verberne HJ, Holleman F.
    Diabetes Res Clin Pract; 2016 Apr; 114():55-63. PubMed ID: 27103370
    [Abstract] [Full Text] [Related]

  • 4. Impact of blood glucose, diabetes, insulin, and obesity on standardized uptake values in tumors and healthy organs on 18F-FDG PET/CT.
    Büsing KA, Schönberg SO, Brade J, Wasser K.
    Nucl Med Biol; 2013 Feb; 40(2):206-13. PubMed ID: 23228852
    [Abstract] [Full Text] [Related]

  • 5. Impact of intravenous insulin on 18F-FDG PET in diabetic cancer patients.
    Roy FN, Beaulieu S, Boucher L, Bourdeau I, Cohade C.
    J Nucl Med; 2009 Feb; 50(2):178-83. PubMed ID: 19164226
    [Abstract] [Full Text] [Related]

  • 6. High and typical 18F-FDG bowel uptake in patients treated with metformin.
    Gontier E, Fourme E, Wartski M, Blondet C, Bonardel G, Le Stanc E, Mantzarides M, Foehrenbach H, Pecking AP, Alberini JL.
    Eur J Nucl Med Mol Imaging; 2008 Jan; 35(1):95-9. PubMed ID: 17786437
    [Abstract] [Full Text] [Related]

  • 7. PET imaging during hypoglycaemia to study adipose tissue metabolism.
    Boss M, Rooijackers HMM, Buitinga M, Janssen MJR, Arens AIJ, de Geus-Oei LF, Salm LP, de Galan BE, Gotthardt M.
    Eur J Clin Invest; 2019 Jul; 49(7):e13120. PubMed ID: 31002171
    [Abstract] [Full Text] [Related]

  • 8. [Appropriate uptake period for myocardial PET imaging with 18F-FDG after oral glucose loading].
    Brink I, Nitzsche EU, Mix M, Schindler T, Hentschel M, Högerle S, Moser E.
    Nuklearmedizin; 2003 Feb; 42(1):39-44. PubMed ID: 12601453
    [Abstract] [Full Text] [Related]

  • 9. The prevalence and clinical significance of (18) F-2-fluoro-2-deoxy-D-glucose (FDG) uptake in the thyroid gland on PET or PET-CT in patients with lymphoma.
    Lin M, Wong C, Lin P, Shon IH, Cuganesan R, Som S.
    Hematol Oncol; 2011 Jun; 29(2):67-74. PubMed ID: 20635328
    [Abstract] [Full Text] [Related]

  • 10. The effect of oral contrast on large bowel activity in FDG-PET/CT.
    Otsuka H, Graham MM, Kubo A, Nishitani H.
    Ann Nucl Med; 2005 Apr; 19(2):101-8. PubMed ID: 15909489
    [Abstract] [Full Text] [Related]

  • 11. Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system.
    Schmidt H, Brendle C, Schraml C, Martirosian P, Bezrukov I, Hetzel J, Müller M, Sauter A, Claussen CD, Pfannenberg C, Schwenzer NF.
    Invest Radiol; 2013 May; 48(5):247-55. PubMed ID: 23519008
    [Abstract] [Full Text] [Related]

  • 12. Semiquantitative Analysis of the Biodistribution of the Combined ¹⁸F-NaF and ¹⁸F-FDG Administration for PET/CT Imaging.
    Minamimoto R, Mosci C, Jamali M, Barkhodari A, Habte F, Jackson T, Mittra E, Gambhir SS, Iagaru A.
    J Nucl Med; 2015 May; 56(5):688-94. PubMed ID: 25840978
    [Abstract] [Full Text] [Related]

  • 13. Comparison of the effect of positive and negative oral contrast agents on (18)F-FDG PET/CT scan.
    Sun XG, Huang G, Liu JJ, Wan LR.
    Hell J Nucl Med; 2009 May; 12(2):115-8. PubMed ID: 19675862
    [Abstract] [Full Text] [Related]

  • 14. 18F-fluorodeoxyglucose positron emission tomography/computed tomography and the relationship between fluorodeoxyglucose uptake and the expression of hypoxia-inducible factor-1α, glucose transporter-1 and vascular endothelial growth factor in thymic epithelial tumours.
    Toba H, Kondo K, Sadohara Y, Otsuka H, Morimoto M, Kajiura K, Nakagawa Y, Yoshida M, Kawakami Y, Takizawa H, Kenzaki K, Sakiyama S, Bando Y, Tangoku A.
    Eur J Cardiothorac Surg; 2013 Aug; 44(2):e105-12. PubMed ID: 23674658
    [Abstract] [Full Text] [Related]

  • 15. Spatial and temporal heterogeneity of regional myocardial uptake in patients without heart disease under fasting conditions on repeated whole-body 18F-FDG PET/CT.
    Inglese E, Leva L, Matheoud R, Sacchetti G, Secco C, Gandolfo P, Brambilla M, Sambuceti G.
    J Nucl Med; 2007 Oct; 48(10):1662-9. PubMed ID: 17873124
    [Abstract] [Full Text] [Related]

  • 16. Optimization of whole-body positron emission tomography imaging by using delayed 2-deoxy-2-[F-18]fluoro-D: -glucose Injection following I.V. Insulin in diabetic patients.
    Turcotte E, Leblanc M, Carpentier A, Bénard F.
    Mol Imaging Biol; 2006 Oct; 8(6):348-54. PubMed ID: 17053859
    [Abstract] [Full Text] [Related]

  • 17. Effects of varying serum glucose levels on 18F-FDG biodistribution.
    Webb RL, Landau E, Klein D, DiPoce J, Volkin D, Belman J, Voutsinas N, Brenner A.
    Nucl Med Commun; 2015 Jul; 36(7):717-21. PubMed ID: 25888357
    [Abstract] [Full Text] [Related]

  • 18. Normal variants of bowel FDG uptake in dual-time-point PET/CT imaging.
    Toriihara A, Yoshida K, Umehara I, Shibuya H.
    Ann Nucl Med; 2011 Apr; 25(3):173-8. PubMed ID: 21088936
    [Abstract] [Full Text] [Related]

  • 19. Effects of pioglitazone on visceral fat metabolic activity in impaired glucose tolerance or type 2 diabetes mellitus.
    Kodama N, Tahara N, Tahara A, Honda A, Nitta Y, Mizoguchi M, Kaida H, Ishibashi M, Abe T, Ikeda H, Narula J, Fukumoto Y, Yamagishi S, Imaizumi T.
    J Clin Endocrinol Metab; 2013 Nov; 98(11):4438-45. PubMed ID: 24030946
    [Abstract] [Full Text] [Related]

  • 20. Myocardial glucose utilization and optimization of (18)F-FDG PET imaging in patients with non-insulin-dependent diabetes mellitus, coronary artery disease, and left ventricular dysfunction.
    Vitale GD, deKemp RA, Ruddy TD, Williams K, Beanlands RS.
    J Nucl Med; 2001 Dec; 42(12):1730-6. PubMed ID: 11752067
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.